Allogeneic Stem Cell Therapy for Acute Ischemic Stroke: The Phase 2/3 TREASURE Randomized Clinical Trial. Houkin K, Osanai T, Uchiyama S, Minematsu K, et al. JAMA Neurol 2024 Jan 16:e235200. doi: 10.1001/jamaneurol.2023.5200.

Read + Share

Amedeo Smart

Independent Medical Education

Houkin K, Osanai T, Uchiyama S, Minematsu K, et al. Allogeneic Stem Cell Therapy for Acute Ischemic Stroke: The Phase 2/3 TREASURE Randomized Clinical Trial. JAMA Neurol 2024 Jan 16:e235200. doi: 10.1001/jamaneurol.2023.5200.
PMID: 38227308